{"id":"https://genegraph.clinicalgenome.org/r/c939c16b-a201-4bc3-9286-9dc33e5ddb64v2.0","type":"EvidenceStrengthAssertion","dc:description":"*SCN1B* was first reported in relation to autosomal dominant generalized epilepsy with febrile seizures plus (GEFS+) in 1998 (Wallace et al., PMID: 9697698). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in inheritance pattern and phenotypic variability. Therefore the following disease entities have been split into multiple disease entities: autosomal dominant GEFS+, autosomal recessive developmental and epileptic encephalopathy (DEE), and autosomal dominant atrial fibrillation or Brugada syndrome. Autosomal recessive DEE has been curated separately by the Epilepsy Gene Curation Expert Panel. This curation focuses only on autosomal dominant GEFS+ and does not include cases with isolated autosomal dominant atrial fibrillation/Brugada syndrome.\n\nEleven variants, including missense, nonsense, and start loss variants, in 15 probands from 11 publications have been included in this curation (PMIDs: 9697698, 14504340, 17020904, 28726809, 30660056, 31729702, 31980526, 35704740, 35886038, 19522081, 12011299). A well-described founder variant (p.Cys121Trp) has also been reported (PMIDs: 9697698, 17020904, 20628201). Variants in this gene were shown to segregate with disease in many additional family members. However, incomplete penetrance (calculated as ~60% in PMID: 9697698) and clinical heterogeneity have been reported. Therefore, there is some uncertainty around whether heterozygous variants in SCN1B might better be described as risk factors as opposed to a typical Mendelian disease of reasonable penetrance. The exact mechanism of disease is currently unknown. \n\nThis gene-disease relationship is also supported by animal models and biochemical experiments revealing gene function (PMIDs: 20628201, 23090990). In summary, there is definitive evidence supporting the relationship between *SCN1B* and GEFS+. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. \n\nOf note, this gene-disease pair was originally evaluated by the ClinGen Epilepsy Gene Curation Expert Panel on January 4, 2022. It was reevaluated on December 13, 2022. As a result of this reevaluation, the classification changed from Moderate to Definitive with the addition of new case data (PMIDs: 35704740, 35886038, 19522081, 12011299) and a new mouse model (PMID: 20628201) (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/c939c16b-a201-4bc3-9286-9dc33e5ddb64","GCISnapshot":"https://genegraph.clinicalgenome.org/r/91fb4b50-478b-4e3a-ac8a-a5cb7634a492","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:sopChange"},{"id":"cg:summaryChange"},{"id":"cg:otherTextChange"},{"id":"cg:classificationChange"},{"id":"cg:newEvidence"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/91fb4b50-478b-4e3a-ac8a-a5cb7634a492_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2023-01-09T21:12:09.783Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/91fb4b50-478b-4e3a-ac8a-a5cb7634a492_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2022-12-13T17:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91fb4b50-478b-4e3a-ac8a-a5cb7634a492_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91fb4b50-478b-4e3a-ac8a-a5cb7634a492_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/318119c3-6222-4d5c-87ce-481a9ccd22ce","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e2d5ac2-73c5-4d72-9f53-b9554186f707","type":"Finding","dc:description":"Voltage-gated sodium channels are essential for creation of action potentials and alterations in these channels are associated with epilepsy (PMID: 33841294)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23090990","rdfs:label":"NaVÎ²1 Interacts with and Modulates KV1.x Channels","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/91fb4b50-478b-4e3a-ac8a-a5cb7634a492_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06d369df-844b-499b-ba35-af81fe5b76a0","type":"EvidenceLine","dc:description":"Currently, the Epilepsy GCEP feels that heat-induced seizures are not as robust of a model for human epilepsies as spontaneous seizures. However, because human febrile seizures can be triggered by elevated core temperatures, the group has decided to award this study one point as a model system for GEFS+ in humans.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/452df5b4-305b-4878-94b6-2243eab98903","type":"Finding","dc:description":"The mice suffered seizures in response to elevated core temperatures. This is similar to the febrile seizures occurring in response to illness, such as fever, in individuals with GEFS+.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20628201","rdfs:label":"Wimmer Mouse Thermal Seizure","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/91fb4b50-478b-4e3a-ac8a-a5cb7634a492_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74d99df5-c3db-4664-bf29-aaaf2018e5e6","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74d99df5-c3db-4664-bf29-aaaf2018e5e6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14504340","allele":{"id":"https://genegraph.clinicalgenome.org/r/3addeb50-f040-4f9c-b2c8-d6db2c4d8d16","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001037.5(SCN1B):c.208-2A>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA254716"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b511c9a9-7dff-40c8-a70f-b6868202e580","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b511c9a9-7dff-40c8-a70f-b6868202e580_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31729702","allele":{"id":"https://genegraph.clinicalgenome.org/r/b19bf33c-24cf-44b4-8a8e-b3b82bc0b717","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001037.5(SCN1B):c.374G>T (p.Arg125Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1058022"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6adeee53-2909-483d-963c-6be320a19530","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6adeee53-2909-483d-963c-6be320a19530_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9697698","allele":{"id":"https://genegraph.clinicalgenome.org/r/24b169e6-61ff-491a-b2b2-05b16f2ad135","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001037.5(SCN1B):c.363C>G (p.Cys121Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA203839"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/6adeee53-2909-483d-963c-6be320a19530_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Co-expression of the mutant Î²1 subunit with a brain Na+-channel Î± subunit in Xenopus laevis oocytes demonstrates that the mutation interferes with the ability of the subunit to modulate channel gating kinetics consistent with a loss-of-function allele. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d4e14c2a-ba6c-4ba7-9ac5-8f391df2ef40","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4e14c2a-ba6c-4ba7-9ac5-8f391df2ef40_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31980526","allele":{"id":"https://genegraph.clinicalgenome.org/r/423115b1-bd78-4183-bbcd-0612d896fae9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001037.5(SCN1B):c.254G>A (p.Arg85His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA144661"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/d4e14c2a-ba6c-4ba7-9ac5-8f391df2ef40_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 17629415 reported that co-expression of the alpha subunit with WT or R85H beta subunits in HEK293T cells revealed that the mutant modulates steady state slow inactivation.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b478f799-a7b8-4d29-bf88-228ffd315eae","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b478f799-a7b8-4d29-bf88-228ffd315eae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28726809","allele":{"id":"https://genegraph.clinicalgenome.org/r/ea6e1bca-940a-4c29-915c-c2921243bdd5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001037.5(SCN1B):c.305_313del (p.Gln102_Ser105delinsPro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573048345"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bda4a254-75f7-4390-841c-d6f2ba27fc3f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bda4a254-75f7-4390-841c-d6f2ba27fc3f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17020904","allele":{"id":"https://genegraph.clinicalgenome.org/r/24b169e6-61ff-491a-b2b2-05b16f2ad135"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/bda4a254-75f7-4390-841c-d6f2ba27fc3f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Co-expression of the mutant Î²1 subunit with a brain Na+-channel Î± subunit in Xenopus laevis oocytes  demonstrates that the mutation interferes with the ability of the subunit to modulate channel gating kinetics consistent with a loss-of-function allele.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/91fb4b50-478b-4e3a-ac8a-a5cb7634a492_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1338556-bc5d-4e89-bd1b-507f62f8fbb5_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17020904","rdfs:label":"Scheffer Family D","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/a1338556-bc5d-4e89-bd1b-507f62f8fbb5","type":"Family","rdfs:label":"Scheffer Family D","member":{"id":"https://genegraph.clinicalgenome.org/r/49172588-1409-4b01-92b7-0ec13b8c1a15","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17020904","rdfs:label":"Scheffer Family D V-5","allele":{"id":"https://genegraph.clinicalgenome.org/r/423115b1-bd78-4183-bbcd-0612d896fae9"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0fa2bd25-0e80-45fa-acd6-9e0f8f2c15bc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17020904","allele":{"id":"https://genegraph.clinicalgenome.org/r/423115b1-bd78-4183-bbcd-0612d896fae9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":7,"phenotypes":"obo:HP_0001250","proband":{"id":"https://genegraph.clinicalgenome.org/r/49172588-1409-4b01-92b7-0ec13b8c1a15"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/a41f69ea-8a07-48c5-84c1-2e9d15599cdf_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31729702","rdfs:label":"Kamoun Family A","family":{"id":"https://genegraph.clinicalgenome.org/r/a41f69ea-8a07-48c5-84c1-2e9d15599cdf","type":"Family","rdfs:label":"Kamoun Family A","member":{"id":"https://genegraph.clinicalgenome.org/r/fc6f3cf1-f0e1-4ae2-a827-1e52d40733d3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31729702","rdfs:label":"Kamoun Family A II-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b19bf33c-24cf-44b4-8a8e-b3b82bc0b717"},"firstTestingMethod":"Linkage analysis","phenotypes":"obo:HP_0001250","secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b511c9a9-7dff-40c8-a70f-b6868202e580_variant_evidence_item"}}},"phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0001250","proband":{"id":"https://genegraph.clinicalgenome.org/r/fc6f3cf1-f0e1-4ae2-a827-1e52d40733d3"}},{"id":"https://genegraph.clinicalgenome.org/r/b7f0af04-cfad-4951-90ca-9d73d6971c49_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17020904","rdfs:label":"Scheffer Family B","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/b7f0af04-cfad-4951-90ca-9d73d6971c49","type":"Family","rdfs:label":"Scheffer Family B","member":{"id":"https://genegraph.clinicalgenome.org/r/0fb7a380-7e56-47e9-842f-1485d6e1e0ae","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17020904","rdfs:label":"Scheffer Family B III-4","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/24b169e6-61ff-491a-b2b2-05b16f2ad135"},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0001250","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/bda4a254-75f7-4390-841c-d6f2ba27fc3f_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"phenotypes":"obo:HP_0001250","proband":{"id":"https://genegraph.clinicalgenome.org/r/0fb7a380-7e56-47e9-842f-1485d6e1e0ae"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/e247f8e0-8d77-47b5-9976-9357d3a3cc58_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9697698","rdfs:label":"Wallace Family","family":{"id":"https://genegraph.clinicalgenome.org/r/e247f8e0-8d77-47b5-9976-9357d3a3cc58","type":"Family","rdfs:label":"Wallace Family","member":{"id":"https://genegraph.clinicalgenome.org/r/28d1da97-45c2-4993-b2f9-789d5ca1bf2b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9697698","rdfs:label":"Wallace Proband V-43","allele":{"id":"https://genegraph.clinicalgenome.org/r/24b169e6-61ff-491a-b2b2-05b16f2ad135"},"firstTestingMethod":"Linkage analysis","phenotypes":"obo:HP_0001250","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6adeee53-2909-483d-963c-6be320a19530_variant_evidence_item"}}},"phenotypePositiveAllelePositive":14,"phenotypes":"obo:HP_0001250","proband":{"id":"https://genegraph.clinicalgenome.org/r/28d1da97-45c2-4993-b2f9-789d5ca1bf2b"},"publishedLodScore":3.85,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/64945a9b-2983-4fac-b7dc-626feaacb47f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17020904","rdfs:label":"Scheffer Family A","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/64945a9b-2983-4fac-b7dc-626feaacb47f","type":"Family","rdfs:label":"Scheffer Family A","member":{"id":"https://genegraph.clinicalgenome.org/r/8e9d5327-9f13-4a16-ae50-c66b2b208b4c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17020904","rdfs:label":"Scheffer Family A III-3","allele":{"id":"https://genegraph.clinicalgenome.org/r/24b169e6-61ff-491a-b2b2-05b16f2ad135"},"detectionMethod":"The coding sequence and flanking intronic regions of SCN1B were sequenced.","firstTestingMethod":"PCR","phenotypeFreeText":"Febrile seizures, temporal lobe epilepsy","phenotypes":"obo:HP_0001250","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3d95f423-2fa8-4064-9a87-6670e5227e56_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17020904","allele":{"id":"https://genegraph.clinicalgenome.org/r/24b169e6-61ff-491a-b2b2-05b16f2ad135"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"phenotypes":"obo:HP_0001250","proband":{"id":"https://genegraph.clinicalgenome.org/r/8e9d5327-9f13-4a16-ae50-c66b2b208b4c"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/343f4147-fbb7-4c0c-ac79-2eb50f8eaa23_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30660056","rdfs:label":"Myers Family A","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/343f4147-fbb7-4c0c-ac79-2eb50f8eaa23","type":"Family","rdfs:label":"Myers Family A","member":{"id":"https://genegraph.clinicalgenome.org/r/ddafdda2-b9c8-45f5-8628-2d1d5a3f621c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30660056","rdfs:label":"Myers Patient A1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/87407819-e614-44a7-aabc-ffb9519dc044","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001037.5(SCN1B):c.1A>T (p.Met1Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA405327769"}},"firstTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4675cf62-9236-4e0b-b129-da176d4db464_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30660056","allele":{"id":"https://genegraph.clinicalgenome.org/r/87407819-e614-44a7-aabc-ffb9519dc044"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ddafdda2-b9c8-45f5-8628-2d1d5a3f621c"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/110abf61-4b55-41aa-a4a8-a2b56e4e64c6_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28726809","rdfs:label":"Strauss Family of Proband 35","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/110abf61-4b55-41aa-a4a8-a2b56e4e64c6","type":"Family","rdfs:label":"Strauss Family of Proband 35","member":{"id":"https://genegraph.clinicalgenome.org/r/3653fe38-0a7d-4bc2-abcb-5253e705feb1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28726809","rdfs:label":"Strauss Proband 35","allele":{"id":"https://genegraph.clinicalgenome.org/r/50636106-5adc-4d1b-ada5-fe6fb6bc23d6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001037.5(SCN1B):c.350G>A (p.Gly117Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA405328841"}},"firstTestingMethod":"Exome sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/22ef0a9e-fee5-42fb-b6b4-0c40b1fd9834_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28726809","allele":{"id":"https://genegraph.clinicalgenome.org/r/50636106-5adc-4d1b-ada5-fe6fb6bc23d6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/3653fe38-0a7d-4bc2-abcb-5253e705feb1"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/960e0452-ad7a-48f3-87d9-b801b76591b9_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17020904","rdfs:label":"Scheffer Family C","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/960e0452-ad7a-48f3-87d9-b801b76591b9","type":"Family","rdfs:label":"Scheffer Family C","member":{"id":"https://genegraph.clinicalgenome.org/r/81073b51-5e9b-49a6-8acd-8b8e1c13e20d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17020904","rdfs:label":"Scheffer Family C IV-6","allele":{"id":"https://genegraph.clinicalgenome.org/r/2a747843-99d1-4c09-ae8a-8f1a2a084eb0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001037.5(SCN1B):c.253C>T (p.Arg85Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA302153"}},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0001250","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/117ab3fc-dc2f-4dbd-8ab4-22519cfb8185_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17020904","allele":{"id":"https://genegraph.clinicalgenome.org/r/2a747843-99d1-4c09-ae8a-8f1a2a084eb0"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0001250","proband":{"id":"https://genegraph.clinicalgenome.org/r/81073b51-5e9b-49a6-8acd-8b8e1c13e20d"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.8},{"id":"https://genegraph.clinicalgenome.org/r/3d95f423-2fa8-4064-9a87-6670e5227e56","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3d95f423-2fa8-4064-9a87-6670e5227e56_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3d95f423-2fa8-4064-9a87-6670e5227e56_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Co-expression of the mutant Î²1 subunit with a brain Na+-channel Î± subunit in Xenopus laevis oocytes  demonstrates that the mutation interferes with the ability of the subunit to modulate channel gating kinetics consistent with a loss-of-function allele.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a9b548aa-5ec4-46eb-a9bf-25700b043873","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a9b548aa-5ec4-46eb-a9bf-25700b043873_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31709768","allele":{"id":"https://genegraph.clinicalgenome.org/r/2a747843-99d1-4c09-ae8a-8f1a2a084eb0"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a9b548aa-5ec4-46eb-a9bf-25700b043873_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 17629415 reported that co-expression of the alpha subunit with WT or R85C beta subunits in HEK293T cells revealed complete LoF","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/117ab3fc-dc2f-4dbd-8ab4-22519cfb8185","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/117ab3fc-dc2f-4dbd-8ab4-22519cfb8185_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/117ab3fc-dc2f-4dbd-8ab4-22519cfb8185_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 17629415 reported that co-expression of the alpha subunit with WT or R85C beta subunits in HEK293T cells revealed complete LoF","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4c769849-558a-43cf-b693-216706bcb5d5","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c769849-558a-43cf-b693-216706bcb5d5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35886038","allele":{"id":"https://genegraph.clinicalgenome.org/r/ca1e55d9-6dfd-4a6d-9556-025de535d5d7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001037.5(SCN1B):c.655T>C (p.Ter219Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA405330348"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4675cf62-9236-4e0b-b129-da176d4db464","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4675cf62-9236-4e0b-b129-da176d4db464_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5d231df0-44be-450d-ab2c-1695cd31cd6a","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d231df0-44be-450d-ab2c-1695cd31cd6a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19522081","allele":{"id":"https://genegraph.clinicalgenome.org/r/d90adb74-f620-4f79-9cca-1a6f10106889","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001037.5(SCN1B):c.73G>A (p.Asp25Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA302190"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/5d231df0-44be-450d-ab2c-1695cd31cd6a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 29992740 found reduced levels of ð›½1 subunit in the cell membrane of human embryonic kidney cells transfected with the c.73G>A variant.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b7ce8098-fe42-482b-8fa4-874bb22a7566","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7ce8098-fe42-482b-8fa4-874bb22a7566_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35704740","allele":{"id":"https://genegraph.clinicalgenome.org/r/cd44a71c-64aa-40d7-ac97-b7d8e5e796d8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001037.5(SCN1B):c.652G>T (p.Glu218Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA405330342"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0fa2bd25-0e80-45fa-acd6-9e0f8f2c15bc","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0fa2bd25-0e80-45fa-acd6-9e0f8f2c15bc_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0fa2bd25-0e80-45fa-acd6-9e0f8f2c15bc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 17629415 reported that co-expression of the alpha subunit with WT or R85H beta subunits in HEK293T cells revealed that the mutant modulates steady state slow inactivation.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/22ef0a9e-fee5-42fb-b6b4-0c40b1fd9834","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/22ef0a9e-fee5-42fb-b6b4-0c40b1fd9834_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/275e01d3-f711-4990-8198-4423600e3756","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/275e01d3-f711-4990-8198-4423600e3756_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12011299","allele":{"id":"https://genegraph.clinicalgenome.org/r/24b169e6-61ff-491a-b2b2-05b16f2ad135"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/275e01d3-f711-4990-8198-4423600e3756_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 9697698 -- Co-expression of the mutant Î²1 subunit with a brain Na+-channel Î± subunit in Xenopus laevis oocytes demonstrates that the mutation interferes with the ability of the subunit to modulate channel gating kinetics consistent with a loss-of-function allele","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":10.7}],"evidenceStrength":"Definitive","sequence":5745,"specifiedBy":"GeneValidityCriteria9","strengthScore":12.2,"subject":{"id":"https://genegraph.clinicalgenome.org/r/H7mdizowPzg","type":"GeneValidityProposition","disease":"obo:MONDO_0018214","gene":"hgnc:10586","modeOfInheritance":"obo:HP_0000006"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_91fb4b50-478b-4e3a-ac8a-a5cb7634a492-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}